DK0460020T3 - Medikamentleveringssammensætninger - Google Patents
MedikamentleveringssammensætningerInfo
- Publication number
- DK0460020T3 DK0460020T3 DK90903612.1T DK90903612T DK0460020T3 DK 0460020 T3 DK0460020 T3 DK 0460020T3 DK 90903612 T DK90903612 T DK 90903612T DK 0460020 T3 DK0460020 T3 DK 0460020T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug delivery
- delivery configurations
- composition
- active compound
- pharmacologically active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898904370A GB8904370D0 (en) | 1989-02-25 | 1989-02-25 | Liquid delivery compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0460020T3 true DK0460020T3 (da) | 1994-05-16 |
Family
ID=10652342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90903612.1T DK0460020T3 (da) | 1989-02-25 | 1990-02-23 | Medikamentleveringssammensætninger |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0460020B2 (da) |
| JP (1) | JP3306779B2 (da) |
| AT (1) | ATE104545T1 (da) |
| CA (1) | CA2045472C (da) |
| DE (1) | DE69008346T3 (da) |
| DK (1) | DK0460020T3 (da) |
| ES (1) | ES2055904T5 (da) |
| GB (1) | GB8904370D0 (da) |
| NO (1) | NO301692B1 (da) |
| WO (1) | WO1990009780A1 (da) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0565618A4 (en) * | 1991-01-03 | 1994-06-29 | Alkermes Inc | Stabilization of proteins by cationic biopolymers |
| PT748213E (pt) | 1994-03-07 | 2004-08-31 | Nektar Therapeutics | Metodos e composicoes para administracao pulmonar de insulina |
| US6054462A (en) * | 1994-04-13 | 2000-04-25 | Janssen Pharmaceutica, N.V. | Intranasal antimigraine compositions |
| HRP950149A2 (en) * | 1994-04-13 | 1997-06-30 | Janssen Pharmaceutica Nv | Intranasal antimigrene composition |
| GB9416884D0 (en) * | 1994-08-20 | 1994-10-12 | Danbiosyst Uk | Drug delivery compositions |
| GB9419979D0 (en) * | 1994-10-04 | 1994-11-16 | Medeva Holdings Bv | Vaccine compositions |
| SE9403905D0 (sv) * | 1994-11-14 | 1994-11-14 | Astra Ab | New formulations |
| US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| JP3098401B2 (ja) * | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
| GB9522351D0 (en) * | 1995-11-01 | 1996-01-03 | Medeva Holdings Bv | Vaccine compositions |
| GB9525083D0 (en) | 1995-12-07 | 1996-02-07 | Danbiosyst Uk | Vaccine compositions |
| US6184037B1 (en) | 1996-05-17 | 2001-02-06 | Genemedicine, Inc. | Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| JP3020141B2 (ja) * | 1996-10-07 | 2000-03-15 | 株式会社富士薬品 | 経鼻投与用製剤 |
| US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| GB9700624D0 (en) | 1997-01-14 | 1997-03-05 | Danbiosyst Uk | Drug delivery composition |
| US6730735B2 (en) | 1997-07-03 | 2004-05-04 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Conjugate of polyethylene glycol and chitosan |
| GB9725084D0 (en) | 1997-11-28 | 1998-01-28 | Medeva Europ Ltd | Vaccine compositions |
| PL193805B1 (pl) * | 1998-07-08 | 2007-03-30 | Kirin Amgen Inc | Preparat w postaci proszku do podawania przez błonę śluzową |
| GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
| CN1543338B (zh) | 2001-08-16 | 2010-06-16 | Cmp医疗有限公司 | 壳多糖微粒及其医疗用途 |
| US7118888B2 (en) * | 2001-09-28 | 2006-10-10 | University Of South Florida Board Of Trustees | Gene expression vaccine |
| US7666876B2 (en) | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
| EP1579001B1 (en) | 2002-04-30 | 2013-02-13 | University Of South Florida | Materials and methods for use in the prevention and treatment of rna viral diseases |
| US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
| US7595303B1 (en) | 2002-09-05 | 2009-09-29 | University Of South Florida | Genetic adjuvants for immunotherapy |
| GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
| GB0310919D0 (en) | 2003-05-13 | 2003-06-18 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
| GB0315632D0 (en) | 2003-07-04 | 2003-08-13 | West Pharm Serv Drug Res Ltd | Pharmaceutical formulations |
| US7625865B2 (en) | 2004-03-26 | 2009-12-01 | Universita Degli Studi Di Parma | Insulin highly respirable microparticles |
| US8399025B2 (en) | 2004-06-04 | 2013-03-19 | Board Of Regents, The University Of Texas System | Polyamine modified particles |
| EP1797870A1 (en) * | 2005-12-14 | 2007-06-20 | The Jordanian Pharmaceutical Manufacturing Co. | Oral delivery of protein drugs using microemulsion |
| AU2007285472B2 (en) | 2006-03-30 | 2013-10-24 | Engene, Inc. | Non-viral compositions and methods for transfecting gut cells in vivo |
| AU2007262845B2 (en) | 2006-06-20 | 2013-07-25 | Mucovax Inc. | Compositions comprising chitin microparticles and their medical uses |
| KR20160106200A (ko) | 2007-02-11 | 2016-09-09 | 맵 파마슈티컬스, 인코포레이티드 | 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 ｄｈｅ의 치료적 투여 방법 |
| JP2010536786A (ja) * | 2007-08-17 | 2010-12-02 | アムジエン・インコーポレーテツド | ポリカチオンを用いた抗体およびｆｃ融合分子の製剤 |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| GB0812742D0 (en) | 2008-07-11 | 2008-08-20 | Critical Pharmaceuticals Ltd | Process |
| JP5670421B2 (ja) | 2009-03-31 | 2015-02-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | コンポーネント表面のコーティング方法 |
| JP5763053B2 (ja) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アダプタ、吸入器具及びアトマイザ |
| EP2504051B1 (en) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| KR101782306B1 (ko) | 2009-11-25 | 2017-09-27 | 베링거 인겔하임 인터내셔날 게엠베하 | 분무기 |
| WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| SG10201607577QA (en) * | 2012-03-15 | 2016-11-29 | Acraf | Glycogen-based cationic polymers |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| WO2014055825A1 (en) | 2012-10-04 | 2014-04-10 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | A formulation of mycobacterial components as an adjuvant for inducing th17 responses |
| WO2014113541A1 (en) | 2013-01-16 | 2014-07-24 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Attenuated chlamydia vaccine |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| WO2015018904A1 (en) | 2013-08-09 | 2015-02-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
| KR102409529B1 (ko) | 2014-05-07 | 2022-06-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 컨테이너, 표시 디바이스 및 분무기 |
| EP3139984B1 (en) | 2014-05-07 | 2021-04-28 | Boehringer Ingelheim International GmbH | Nebulizer |
| WO2015169732A1 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3250023T (da) * | 1981-01-14 | 1990-03-29 |
-
1989
- 1989-02-25 GB GB898904370A patent/GB8904370D0/en active Pending
-
1990
- 1990-02-23 ES ES90903612T patent/ES2055904T5/es not_active Expired - Lifetime
- 1990-02-23 DK DK90903612.1T patent/DK0460020T3/da active
- 1990-02-23 AT AT9090903612T patent/ATE104545T1/de not_active IP Right Cessation
- 1990-02-23 WO PCT/GB1990/000291 patent/WO1990009780A1/en active IP Right Grant
- 1990-02-23 JP JP50363790A patent/JP3306779B2/ja not_active Expired - Lifetime
- 1990-02-23 CA CA002045472A patent/CA2045472C/en not_active Expired - Lifetime
- 1990-02-23 EP EP90903612A patent/EP0460020B2/en not_active Expired - Lifetime
- 1990-02-23 DE DE69008346T patent/DE69008346T3/de not_active Expired - Lifetime
-
1991
- 1991-07-23 NO NO912870A patent/NO301692B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0460020B2 (en) | 1997-09-17 |
| DE69008346D1 (de) | 1994-05-26 |
| CA2045472A1 (en) | 1990-08-26 |
| WO1990009780A1 (en) | 1990-09-07 |
| NO301692B1 (no) | 1997-12-01 |
| GB8904370D0 (en) | 1989-04-12 |
| CA2045472C (en) | 2000-01-04 |
| NO912870D0 (no) | 1991-07-23 |
| ATE104545T1 (de) | 1994-05-15 |
| EP0460020B1 (en) | 1994-04-20 |
| ES2055904T3 (es) | 1994-09-01 |
| ES2055904T5 (es) | 1998-01-01 |
| JP3306779B2 (ja) | 2002-07-24 |
| EP0460020A1 (en) | 1991-12-11 |
| DE69008346T3 (de) | 1998-01-08 |
| DE69008346T2 (de) | 1994-08-25 |
| NO912870L (no) | 1991-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0460020T3 (da) | Medikamentleveringssammensætninger | |
| ES2162927T3 (es) | Formulacion para la aplicacion por inhalacion. | |
| DE3689983D1 (de) | Arzneimittel mit langsamer Wirkstofffreisetzung. | |
| DE3868037D1 (de) | Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe. | |
| ES8800055A1 (es) | Procedimiento para la preparacion de una composicion que contiene una sal de acido hialuronico. | |
| MXPA03011538A (es) | Composicion medicinal que sustancialmente no causaria dano a la mucosa intestinal. | |
| DE69022876D1 (de) | Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe. | |
| AU7465087A (en) | Controlled release bioerodible drug delivery system | |
| BR9911070A (pt) | Sistema de liberação de droga compreendendo uma matéria-prima de medicamento sólido acentuadamente compacto | |
| AR026978A1 (es) | Sistema de medicamentos en polvo e inhalador provisto con el | |
| CA2067228A1 (en) | Drug delivery system, method for preparing the same and use thereof | |
| KR880010758A (ko) | 서방성 제제 | |
| BE1000722A4 (fr) | Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale. | |
| MY102411A (en) | Nasal solutions | |
| IT1204400B (it) | Composizioni farmaceutiche contenente una calcitonina | |
| DE69225053D1 (de) | Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung | |
| DE69222295D1 (de) | Pulverförmige pharmazeutische Zusammensetzung | |
| AR012996A1 (es) | Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador. | |
| AU2503900A (en) | Sulfated phosphatidylinositols, their preparation and use | |
| BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
| BR9808876A (pt) | Sistema de liberação de medicamento | |
| KR920016104A (ko) | 노인성 특발적 백내장 약제 제조를 위한 칼시토닌의 국소적용 용도 및 이의 약제학적 조성물 | |
| BG103023A (en) | Bronchodilatation medicamentous form | |
| ITRM910038A1 (it) | Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale. |